当前位置: X-MOL 学术Hum. Genome Var. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel SLC20A2 variant in a Japanese patient with idiopathic basal ganglia calcification-1 (IBGC1) associated with dopa-responsive parkinsonism.
Human Genome Variation Pub Date : 2019-09-04 , DOI: 10.1038/s41439-019-0073-7
Yaeko Ichikawa 1 , Masaki Tanaka 2, 3 , Eriko Kurita 1 , Masanori Nakajima 1 , Masaki Tanaka 1 , Chizuko Oishi 1 , Jun Goto 4 , Shoji Tsuji 2, 3, 5 , Atsuro Chiba 1
Affiliation  

Idiopathic basal ganglia calcification-1 (IBGC1) is an autosomal dominant disorder characterized by calcification in the basal ganglia, which can manifest a range of neuropsychiatric symptoms, including parkinsonism. We herein describe a 64-year-old Japanese IBGC1 patient with bilateral basal ganglia calcification carrying a novel SLC20A2 variant (p.Val322Glufs*92). The patient also presented with dopa-responsive parkinsonism with decreased dopamine transporter (DAT) density in the bilateral striatum and decreased cardiac 123I-meta-iodobenzylguanidine uptake.

中文翻译:

日本患者特发性基底节神经钙化1(IBGC1)与多巴反应性帕金森病相关的新型SLC20A2变异。

特发性基底神经节钙化1(IBGC1)是一种常染色体显性遗传疾病,其特征在于基底神经节钙化,可表现出一系列神经精神病学症状,包括帕金森氏病。我们在这里描述了一个64岁的日本IBGC1患者,其双侧基底神经节钙化携带一种新型SLC20A2变体(p.Val322Glufs * 92)。该患者还表现出多巴反应性帕金森病,双侧纹状体的多巴胺转运蛋白(DAT)密度降低,心脏123I-间碘碘苄基胍吸收降低。
更新日期:2019-09-04
down
wechat
bug